IDH1 and astrocytic tumor: In 2021, the WHO classification of tumors of the central nervous system restricted the diagnosis of GBM to IDH-wild type astrocytic tumor and reclassified all IDH-mutant diffuse astrocytic tumors as CNS WHO 2–4 [2].